Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell -2021/22 group results

May 13 (Reuters)- 
          Reprocell Incorporated 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to        NEXT   
              Mar 31, 2022    Mar 31, 2021    Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           2.23            1.29            2.48                  
               (+73.7 pct)     (+7.2 pct)     (+10.8 pct)               
  Operating   loss 647 mln      loss 1.05     loss 280 mln              
  Recurring   loss 507 mln    loss 788 mln    loss 136 mln              
  Net
  Net         loss 575 mln    loss 812 mln    loss 136 mln              
  EPS         loss 7.57 yen  loss 11.38 yen  loss 1.66 yen              
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
  
  NOTE - Reprocell Incorporated.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news